专利检索 ap:("Ho Man Chan" OR "Xiang-Ju Justin Gu" OR "Ying Huang" OR "Ling Li" OR "Yuan Mi" OR "Wei Qi" OR "Martin Sendzik" OR "Yongfeng Sun" OR "Long Wang" OR "Zhengtian Yu" OR "Hailong Zhang" OR "Ji Yue (Jeff) Zhang" OR "Man Zhang" OR "Qiong Zhang" OR "Kehao Zhao") AND inv:"Xiang-Ju Justin Gu" 第 1 页

1.

发明授权
Triazolopyrimidine compounds and uses thereof 有权
标题翻译：三唑并嘧啶化合物及其用途

公开(公告)号：US09580437B2

公开(公告)日：2017-02-28

申请号：US14977273

申请日：2015-12-21

申请人： Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao

发明人： Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao

IPC分类号： C07D487/04 , A61K31/519 , A61K31/541 , A61K31/551 , A61K45/06 , A61K31/5377

CPC分类号： A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K45/06 , C07D487/04

摘要： A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

摘要翻译： 提供式（I）化合物或其药学上可接受的盐，其已被证明可用于治疗PRC2介导的疾病或病症：其中R1，R2，R3，R4，R5和n如所定义这里。